"416275" . . . "ECT; venlafaxine; depressive disorder; self-report inventories; bipolar depression"@en . "11120" . "BACKGROUND: The aim of our study was to evaluate the efficacy of electroconvulsive (ECT) and venlafaxine therapy from the patient's point of view. METHODS: We used a retrospective chart review from 22 inpatients who underwent ECT and 22 patients treated with venlafaxine due to resistant unipolar or bipolar depression. We used bilateral ECT in a median of 8 (IQR 7-9.7) sessions and venlafaxine therapy with a median daily dosage of 225 mg (IQR 150-225 mg) for a median of 4 (IQR 4-5) weeks. The main outcome was change in a self-evaluation scale - Short Form of the Beck Depression Inventory (BDI-SF). The response was defined as the decreasing of the BDI-SF score by >/=50%, remission as decreasing of BDI-SF score . "V\u00FDchodiska: C\u00EDlem studie bylo zhodnotit efektivitu elektrokonvulzivn\u00ED terapie (EKT) a l\u00E9\u010Dby venlafaxinem z pohledu pacient\u016F. Metody: Pou\u017Eili jsme hospitaliza\u010Dn\u00ED z\u00E1znamy 22 pacient\u016F, kte\u0159\u00ED byli l\u00E9\u010Deni EKT a 22 pacient\u016F l\u00E9\u010Den\u00FDch venlafaxinem pro rezistentn\u00ED unipol\u00E1rn\u00ED \u010Di bipol\u00E1rn\u00ED depresivn\u00ED poruchu. Byla pou\u017Eita bilater\u00E1ln\u00ED EKT s medi\u00E1nem 8 sezen\u00ED (IQR 7-9.7) a medi\u00E1n denn\u00ED d\u00E1vky venlafaxinu 225 mg (IQR 150-225 mg) po dobu medi\u00E1nu 4 t\u00FDdn\u016F (IQR 4-5 t\u00FDdn\u016F). Hlavn\u00ED prom\u011Bnou byla zm\u011Bna intenzity deprese hodnocena sebeposuzovac\u00ED \u0161k\u00E1lou - Kr\u00E1tk\u00E1 verze - Beckova invent\u00E1\u0159e \u00FAzkosti (BDI-SF). Odpov\u011B\u010F byla definov\u00E1na jako pokles sk\u00F3ru o >/=50%, remise pak jako sn\u00ED\u017Een\u00ED sk\u00F3ru BDI-SF "RIV/00216208:11120/07:00000328!RIV08-MSM-11120___" . "Raszka, Michal" . "P(1M0517), Z(MSM0021620816)" . "6" . "Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy"@en . . . . "28" . . "3"^^ . . . "889-894" . "SE - \u0160v\u00E9dsk\u00E9 kr\u00E1lovstv\u00ED" . . . "Bare\u0161, Martin" . "0172-780X" . "[3EDCF515A861]" . "6"^^ . . . . "6"^^ . "Kope\u010Dek, Miloslav" . . "\u0160ulak, J." . "Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy"@en . . . . . "Seifertov\u00E1, Dagmar" . "Posouzen\u00ED efektivity elektrokonvulzivn\u00ED terapie a l\u00E9\u010Dby venlafaxinem z pohledu depresivn\u00EDch pacient\u016F"@cs . "Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy" . "Posouzen\u00ED efektivity elektrokonvulzivn\u00ED terapie a l\u00E9\u010Dby venlafaxinem z pohledu depresivn\u00EDch pacient\u016F"@cs . "RIV/00216208:11120/07:00000328" . . "Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy" . "Neuroendocrinology Letters" . "BACKGROUND: The aim of our study was to evaluate the efficacy of electroconvulsive (ECT) and venlafaxine therapy from the patient's point of view. METHODS: We used a retrospective chart review from 22 inpatients who underwent ECT and 22 patients treated with venlafaxine due to resistant unipolar or bipolar depression. We used bilateral ECT in a median of 8 (IQR 7-9.7) sessions and venlafaxine therapy with a median daily dosage of 225 mg (IQR 150-225 mg) for a median of 4 (IQR 4-5) weeks. The main outcome was change in a self-evaluation scale - Short Form of the Beck Depression Inventory (BDI-SF). The response was defined as the decreasing of the BDI-SF score by >/=50%, remission as decreasing of BDI-SF score "\u010Cern\u00E1, L." . .